UV-Aid Technology

Stay Healthy with UV-Aid

UV-Aid’s ground breaking patented technology helps prevent the common cold, flu, sore throats, and ear infections safely and effectively by stimulating the body’s immune system to kill bacteria and viruses in the ear, nose, and throat where infections begin and continues to maintain good health through the production of antibodies and memory immune cells. UV-Aid helps prevent viral infections of all types including the Corona Virus or COVID19. The number of documented viruses is nearly 5000. The estimated number of undocumented viruses is in the millions! Antibiotics do not work on viruses, vaccines are required, and a single vaccine works only on one virus. The costs associated with developing even a single vaccine are staggering and if the virus mutates the vaccine is ineffective. The threshold of an approved vaccine is only 50%. On the other hand, the process of photo-oxidation produces hydrogen peroxide that in turn attracts white blood cells that effectively kill or disable harmful viruses and bacteria. UV-Aid provides a safe and effective way to help protect you from air-borne pathogens like COVID19.

This is what we know about COVID19: it is deadly, maybe many times more deadly than the common flu, can live on surfaces for days, is transmitted through the air, and is very contagious as multiple and large clusters are forming on a daily basis. One reason why the virus is so dangerous is that in some cases it incubates for days or weeks before showing symptoms in patients. Reportedly, COVID19 surrounds itself with fat or lipid cells to shield itself from the immune system.

On April 17, 2020 we received a letter from the National Institutes of Health (NIH) stating the following, “The UV-Aid device has a primary mechanism of action that is therapeutic since the premise is that the UV-A light inactivates enveloped (COVID19) viruses that may be in the ear, nose, or throat. While the second mechanism of action is activation of select immune cells” 

How UV-Aid Works: 

COVID19 is more difficult for the immune system to detect and kill because of its lipid outer shell, but the lipid outer shell in turn makes it more susceptible to UVA radiation. UVA radiation via lipid peroxidation acts to weaken the defenses of COVID19 by breaking the methylene bridges(-CH2-) in the lipid cells that surround the virus. The lipid cells while effective in shielding the COVID19 from the immune system act as an effective “electron band gap bridge” allowing UVA (with lower band gap energy vs UVB and UVC) to weaken COVID19 via a cascading effect releasing free radicals from the breaking of the lipid’s methylene bridges.

Second, the same UVA light produces hydrogen peroxide (H2O2) when incident on skin via photo-oxidation. H2O2 is an effective anti-viral and anti-bacterial compound and a chemokine, a signaling agent of white blood cells released by body when the surface of skin is disturbed with the possible threat of infection. Phagocytic cells in turn engulf, kill, and present the pathogen’s (COVID19) antigens preparing the adaptive immune system for the next occurrence with memory, plasma cells, and antibodies.

Third, UVA radiation enhances T lymphocytes motility in skin. T lymphocytes possess intrinsic photosensitivity and play key roles in the innate and adaptive immune systems helping the body ward of pathogens like COVID19. The subsequent creation of adaptive immune cells is based on interactions with live viruses in human cells. This contrasts with traditional vaccinations that utilize dead, weak, or partial viruses grown in non-human cells to elicit an immune response. However, UV-Aid may be used as an effective therapeutic and/ or adjuvant with traditional vaccines as well. This process also works on all types of viral and bacterial infections. Also, of significant importance, this process is all natural with minimal side-effects. UVA exposure is ubiquitous. The human body is well adapted to UVA exposure especially at the low exposure levels associated with UV-Aid. UVA light has been proven safe on skin by multiple independent studies. UVA treatments are reimbursed by Medicare, NCD Section 250.1, delivering exposures over 1000x greater than those required by UV-Aid. To date, the only side effect commonly reported from UV-Aid usage is a slight discharge from the nasal area. PLEASE NOTE: UV-Aid DOES NOT USE UVC or UVB LIGHT. THE TYPE OF LIGHT UV-Aid EXCLUSIVELY USES IS UVA LIGHT.

Since the COVID19 is effectively transmitted through the air, the respiratory system is at high risk. Using a directed beam of UV-Aid light in the nose, throat, and ear helps weaken the pathogen and keeps the immune system on high alert and greatly increases the likelihood that the COVID19 does not go undetected before it caused a full-fledged infection. When UV-Aid light is directed into the ear, nose, and throat, the human immune system reacts to this and sends its full complement of local immunological defenses. UV-Aid technology has demonstrated over ten years to be highly effective in preventing a broad base of airborne bacterial and viral infections from occurring. Click on the video below that graphically explains how UV-Aid helps keep you healthy. 

Supporting Research: 

UV-Aid’s light helps the body kill germs in the ear, nose, and throat where infection starts. Areas of skin exposed to UV-Aid produce hydrogen peroxide through a process called photo-oxidation. Hydrogen peroxide’s role in signaling the immune system to a specific area in the body has been studied extensively over the past 10 years. The ground breaking study by Harvard Medical School published in Nature, June 2009 reported, “the first evidence that H2O2 signals to leukocytes (white blood cells) in tissues”  Since then other researchers have come to the same conclusion including the University of Bristol. In their study, hydrogen peroxide is shown in real time attracting neutrophils (an early responding white blood cell) in a living organism. 

In a study published in Nature (December 2016) it was reported that other white blood cells called “T helper cells” located near the surface of the skin are activated by wavelengths of light emitted by UV-Aid. T cells work fight infections and signal other white blood cells to the area of infection. T Cells called memory cells continue to work to long term to keep the body free from infection. Watch Video.

It only takes a few seconds for the UV-Aid light directed into your mouth, nasal, and ear cavities to produce the necessary amount of hydrogen peroxide. Once the hydrogen peroxide (H2O2) has performed its task of attracting white blood cells and killing germs, the body breaks it down into the harmless by-products of water (H2O) and oxygen (O). Nature’s perfect solution to preventing infection and illness! UV-Aid is safe for you and all your family. A single treatment to your ear, nose and throat is equivalent to being outdoors for less than a second. After TEN years on the market and millions of supplement treatments, UV-Aid has earned over a 95% customer satisfaction record.  Customers use UV-Aid for the prevention of a wide range of ailments, including colds, flu, sore throats, and ear infections. UV-Aid users that used to suffer and average of 5-6 colds a year are now reporting an average 0-1 per year. Click on tab above to read customer testimonials.


We invite you to visit us on Facebook to join our growing community of over 4,000 fans. 

UV-Aid for Nasal Passages

Frequently Asked Questions:

How do I use UV-Aid? You can turn on UV-Aid by either using the small switch or pressing the back side of the unit (side away from the UV-Aid label). If you use the switch remember to turn it off after use, otherwise you will run down your batteries. Apply the light emitted from UV-Aid to both your nostrils, back of throat, and both ears. Use as directed. You will find exposure times on the backside of the blue insert card packaged with your UV-Aid. Keep this card for future exposure reference and for testing the strength of your UV-Aid’s batteries. Point the UV-Aid light at your blue card. You will see it glow. When the light gets noticably dimmer, it is time for new batteries (batteries usually last 4-6 months) .

Is UV-Aid safe? Yes, a single UV-Aid treatment is equivalent to less than a second of exposure to the sun. 

Does UV-Aid use the same type of UV light used to sterilize surgical and other instruments? No. The type of light used to sterilize objects is UVC light. UV-Aid only uses UVA light which has been proven to be safe and effective on the skin.

Is UV-Aid more effective than washing your hands? Hand washing will always be an important defense against disease, however, it does not prevent airborne transmission. UV-Aid kills germs in areas of your body that are hard to reach such as your nasal cavities and throat where diseases fester and start.

Is there proof UV-Aid works? Recently, many researchers have confirmed the role hydrogen peroxide plays in marshaling the innate immune response. In addition, the germ killing abilities of hydrogen peroxide are well known. UV Technologies sponsored laboratory studies have shown a dramatic decrease in bacterial colony counts when human skin is exposed to UV-Aid light. UV-Aid has earned over a 95% customer satisfaction rating over ten years on the market helping to prevent bacterial and viral infections, including colds, flu, and ear infections. 

Why hasn’t anyone thought of this before? Kevin McGuire, founder and President of UV Technologies has over twenty patents related to UV light, daylight, and other light sources. He developed UV-Aid after suffering from chronic asthma, multiple colds (4-5) every year, in addtion to flu, and and two bouts of pneumonia while living in Western NY. After unsuccessfully trying all the traditional treatments like, Vitamin C, Saline Sprays, and over the counter cold products, he discovered his symptoms almost immediately disappeared after exposing his nasal passages to UVA light. In the 10+ years of using his invention, Kevin has had only two minor colds and he has been free of any bacterial or viral infection for the past 6 years. His asthma is gone.

Will I get sunburn from UV-Aid? No. UV-aid uses UVA rays. UVA rays do not burn the skin, only shorter UVB rays cause sunburn. 

Is it safe for children? Yes, if you follow the suggested exposure limits. UV-Aid exposes your child to much less UV than if you took a stroll with them outside. 

When should I use UV-Aid? Use UV-Aid before you go out in the morning, before you go to bed, and other times throughout the day when you feel youve come in contact with someone who is sick or if you feel any tickle in your nose or soreness in your throat. Do Not Use More Than 4 Times a Day. Also wash or disinfect your hands as UV-Aid cannot help stop infections caused by germs transmitted from the hands to eyes.

How does UV-Aid help prevent ear infections? The inner ear has one of the highest concentrations of melanin in the body. Melanin produces hydrogen peroxide. We recommend using UV-Aid on ears as a matter of practice to help prevent ear infections.

UV-Aid for Ear Infections

Is it safe to shine it in my eyes?  NO! We do not recommend you shine any form light in your eyes, but in the event you accidentally shine the light in your eyes, the amount of UV your eyes are exposed to outdoors is many times the UV emitted by UV-Aid.

Do you guarantee it will work? Good hygiene, rest, and good eating habits supplemented with the use of UV-Aid is the best way to remain healthy. Good health is achieved with a proper balance of all the elements.

When should I use UV-Aid? Use UV-Aid before you go out in the morning, before you go to bed, and other times in the day when you’ve come in contact with large crowds or with someone who is sick, or you feel a tickle in your nose or throat. Do not use more than four times a day and use as directed.

How long is my UV-Aid guaranteed for? We guarantee UV-Aid for two years except for batteries.

What is the best way to administer UV-Aid?  We recommend using a mirror in your bathroom, in your purse, or car to confirm accurate aim of the UV light, otherwise with practice you get better without a visual aid.

Are there any side effects? Occasionally you may get a tin-like taste in your mouth or a slight discharge from the nose. These minor side effects are reminders UV-Aid is working.

Can I get reimbursed by my health insurance company for the cost? No, not at this time

In addition to helping prevent colds and flu, can UV-Aid help prevent bad breath? Yes, the hydrogen peroxide created with UV-Aid address areas in your passages that liquid mouth washes cannot get to.

Relevant Studies: (White Paper available on Request)

1. Lofgren, E., N. H. Fefferman, Y. N. Naumov, J. Gorski, and E. N. Naumova. 2007. Influenza seasonality: underlying causes and modeling theories. J Virol 81: 5429-5436.
2. Zhixiang Zhou, S. 2009. A seasonal influenza theory and mathematical model incorporating meteorological and socio-behavioral factors.
3. Ahmed, S., N. L. Shapiro, and N. Bhattacharyya. 2014. Incremental health care utilization and costs for acute otitis media in children. The Laryngoscope 124: 301-305.
4. Bramley, T. J., D. Lerner, and M. Sames. 2002. Productivity losses related to the common cold. Journal of occupational and environmental medicine 44: 822-829.
5. Boktor, S. W., and J. W. Hafner. 2017. Influenza. In StatPearls. StatPearls Publishing StatPearls Publishing LLC., Treasure Island (FL).
6. Fox, S. J., J. C. Miller, and L. A. Meyers. 2017. Seasonality in risk of pandemic influenza emergence. PLoS Comput Biol 13: e1005749.
7. Fendrick, A., A. S. Monto, B. Nightengale, and M. Sarnes. 2003. The economic burden of non–influenza-related viral respiratory tract infection in the united states. Archives of Internal Medicine 163: 487-494.
8. Molinari, N. A., I. R. Ortega-Sanchez, M. L. Messonnier, W. W. Thompson, P. M. Wortley, E. Weintraub, and C. B. Bridges. 2007. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25: 5086-5096.
9. Dicpinigaitis, P. V., R. Eccles, M. S. Blaiss, and M. A. Wingertzahn. 2015. Impact of cough and common cold on productivity, absenteeism, and daily life in the United States: ACHOO Survey. Current Medical Research and Opinion 31: 1519-1525.
10. Salo, H. M., E. I. Jokinen, S. E. Markkula, T. M. Aaltonen, and H. T. Penttila. 2000. Comparative effects of UVA and UVB irradiation on the immune system of fish. Journal of photochemistry and photobiology. B, Biology 56: 154-162.
11. Schmitt, D. A., and S. E. Ullrich. 2000. Exposure to Ultraviolet Radiation Causes Dendritic Cells/Macrophages to Secrete Immune-Suppressive IL-12p40 Homodimers. The Journal of Immunology 165: 3162.
12. Allan, G. M., and B. Arroll. 2014. Prevention and treatment of the common cold: making sense of the evidence. CMAJ : Canadian Medical Association Journal 186: 190-199.
13. Bischoff, W. E., M. L. Wallis, B. K. Tucker, B. A. Reboussin, M. A. Pfaller, F. G. Hayden, and R. J. Sherertz. 2006. “Gesundheit!” Sneezing, Common Colds, Allergies, and Staphylococcus aureus Dispersion. The Journal of Infectious Diseases 194: 1119-1126.
14. Turner, R. B. 2010. Hand Disinfection May Not Prevent Rhinovirus, Influenza Virus Transmission. In MedScape Medical News. A. Goodman, ed. WedMD, LLC, Medscape.com.
15. Turner, R. B., J. L. Fuls, N. D. Rodgers, H. B. Goldfarb, L. K. Lockhart, and L. B. Aust. 2012. A randomized trial of the efficacy of hand disinfection for prevention of rhinovirus infection. Clin Infect Dis 54: 1422-1426.
16. De Fabo, E. C., F. P. Noonan, T. Fears, and G. Merlino. 2004. Ultraviolet B but not ultraviolet A radiation initiates melanoma. Cancer research 64: 6372-6376.
17. Meinhardt, M., R. Krebs, A. Anders, U. Heinrich, and H. Tronnier. 2008. Wavelength-dependent penetration depths of ultraviolet radiation in human skin. Journal of biomedical optics 13: 044030.
18. Mohania, D., S. Chandel, P. Kumar, V. Verma, K. Digvijay, D. Tripathi, K. Choudhury, S. K. Mitten, and D. Shah. 2017. Ultraviolet Radiations: Skin Defense-Damage Mechanism. Adv Exp Med Biol 996: 71-87.
19. Sutherland, J. C., and K. P. Griffin. 1981. Absorption spectrum of DNA for wavelengths greater than 300 nm. Radiation research 86: 399-409.
20. Banerjee, S., and M. Leptin. 2014. Systemic response to ultraviolet radiation involves induction of leukocytic IL-1beta and inflammation in zebrafish. J Immunol 193: 1408-1415.
21. Hoel, D. G., M. Berwick, F. R. de Gruijl, and M. F. Holick. 2016. The risks and benefits of sun exposure 2016. Dermatoendocrinol 8: e1248325.
22. van Schanke, A., M. J. Jongsma, R. Bisschop, G. M. van Venrooij, H. Rebel, and F. R. de Gruijl. 2005. Single UVB overexposure stimulates melanocyte proliferation in murine skin, in contrast to fractionated or UVA-1 exposure. J Invest Dermatol 124: 241-247.
23. D’Orazio, J., S. Jarrett, A. Amaro-Ortiz, and T. Scott. 2013. UV Radiation and the Skin. International Journal of Molecular Sciences 14: 12222-12248.
24. Mitchell, D. L., A. A. Fernandez, R. S. Nairn, R. Garcia, L. Paniker, D. Trono, H. D. Thames, and I. Gimenez-Conti. 2010. Ultraviolet A does not induce melanomas in a Xiphophorus hybrid fish model. Proceedings of the National Academy of Sciences 107: 9329-9334.
25. Wood, S. R., M. Berwick, R. D. Ley, R. B. Walter, R. B. Setlow, and G. S. Timmins. 2006. UV causation of melanoma in Xiphophorus is dominated by melanin photosensitized oxidant production. Proceedings of the National Academy of Sciences of the United States of America 103: 4111-4115.
26. Feelisch, M., V. Kolb-Bachofen, D. Liu, J. O. Lundberg, L. P. Revelo, C. V. Suschek, and R. B. Weller. 2010. Is sunlight good for our heart? Eur Heart J 31: 1041-1045.
27. Liu, D., B. O. Fernandez, A. Hamilton, N. N. Lang, J. M. C. Gallagher, D. E. Newby, M. Feelisch, and R. B. Weller. 2014. UVA irradiation of human skin vasodilates arterial vasculature and lowers blood pressure independently of nitric oxide synthase. J Invest Dermatol 134: 1839-1846.
28. Alexander, J. S., and J. W. Elrod. 2002. Extracellular matrix, junctional integrity and matrix metalloproteinase interactions in endothelial permeability regulation. J Anat 200: 561-574.
29. Cook-Mills, J. M. 2006. Hydrogen peroxide activation of endothelial cell-associated MMPs during VCAM-1-dependent leukocyte migration. Cell Mol Biol (Noisy-le-grand) 52: 8-16.
30. Wittmann, C., P. Chockley, S. K. Singh, L. Pase, G. J. Lieschke, and C. Grabher. 2012. Hydrogen Peroxide in Inflammation: Messenger, Guide, and Assassin. Advances in Hematology 2012: 6.
31. Bedard, K., and K. H. Krause. 2007. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87: 245-313.
32. Tang, D., Y. Shi, R. Kang, T. Li, W. Xiao, H. Wang, and X. Xiao. 2007. Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J Leukoc Biol 81: 741-747.
33. Munakata, T., U. Semba, Y. Shibuya, K. Kuwano, M. Akagi, and S. Arai. 1985. Induction of interferon-gamma production by human natural killer cells stimulated by hydrogen peroxide. J Immunol 134: 2449-2455.
34. Ludwig, S., and O. Planz. 2008. Influenza viruses and the NF-kappaB signaling pathway – towards a novel concept of antiviral therapy. Biological chemistry 389: 1307-1312.
35. Vile, G., Tanew-Iliitschew, A, Tyrrell, RM. 1995. ACTIVATION OF NF-KB IN HUMAN SKIN FIBROBLASTS BY THE OXIDATIVE STRESS GENERATED BY UVA RADIATION. Photochemistry and photobiology 62: 463-468.
36. Yoo, S. K., T. W. Starnes, Q. Deng, and A. Huttenlocher. 2011. Lyn is a redox sensor that mediates leukocyte wound attraction in vivo. Nature 480: 109-112.
37. Byamba, D., T. G. Kim, D. H. Kim, J. H. Je, and M. G. Lee. 2010. The Roles of Reactive Oxygen Species Produced by Contact Allergens and Irritants in Monocyte-derived Dendritic Cells. Ann Dermatol 22: 269-278.
38. Ring, J., B. Przybilla, and B. Eberlein. 1989. Ultraviolet A inhibits histamine release from human peripheral leukocytes. International archives of allergy and applied immunology 88: 136-138.
39. de Paulis, A., G. Monfrecola, L. Casula, E. Prizio, L. Di Gioia, M. Carfora, I. Russo, G. de Crescenzo, and G. Marone. 2003. 8-Methoxypsoralen and long-wave ultraviolet A inhibit the release of proinflammatory mediators and cytokines from human Fc epsilon RI+ cells: an in vitro study. Journal of photochemistry and photobiology. B, Biology 69: 169-177.
40. Valejo Coelho, M. M., T. R. Matos, and M. Apetato. 2016. The dark side of the light: mechanisms of photocarcinogenesis. Clinics in dermatology 34: 563-570.
41. Salganik, R. I. 2001. The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. Journal of the American College of Nutrition 20: 464S-472S; discussion 473S-475S.
42. Mitchell, D., L. Paniker, G. Sanchez, Z. Bella, E. Garaczi, M. Szell, Q. Hamid, L. Kemeny, and A. Koreck. 2010. Molecular response of nasal mucosa to therapeutic exposure to broad-band ultraviolet radiation.
42A. Jean Krutmann, MDAkimichi Morita. UVA1 phototherapy, Journal of Cellular and Molecular Medicine 14: 313-32
43. Wollweber, R. Krebs, A. Anders, U. Heinrich, and H. Tronnier. 2008. Wavelength-dependent penetration depths of ultraviolet radiation in human skin.
44. Oktyabrsky, O. N., and G. V. Smirnova. 2007. Redox regulation of cellular functions. Biochemistry. Biokhimiia 72: 132-145.
45. Rutault, K., C. Alderman, B. M. Chain, and D. R. Katz. 1999. Reactive oxygen species activate human peripheral blood dendritic cells. Free Radic Biol Med 26: 232-238.
46. Phan, T. X., B. Jaruga, S. C. Pingle, B. C. Bandyopadhyay, and G. P. Ahern. 2016. Intrinsic Photosensitivity Enhances Motility of T Lymphocytes. Scientific Reports 6: 39479.
47. Halama, A. R., S. Decreton, J. M. Bijloos, and P. A. Clement. 1990. Density of epithelial cells in the normal human nose and the paranasal sinus mucosa. A scanning electron microscopic study. Rhinology 28: 25-32.
48. Clark, R. A., B. Chong, N. Mirchandani, N. K. Brinster, K. Yamanaka, R. K. Dowgiert, and T. S. Kupper. 2006. The vast majority of CLA+ T cells are resident in normal skin. J Immunol 176: 4431-4439.
49. Jahnsen, F. L., I. N. Farstad, J. P. Aanesen, and P. Brandtzaeg. 1998. Phenotypic distribution of T cells in human nasal mucosa differs from that in the gut. Am J Respir Cell Mol Biol 18: 392-401.
50. Nantz, M. P., C. A. Rowe, C. Muller, R. Creasy, J. Colee, C. Khoo, and S. S. Percival. 2013. Consumption of cranberry polyphenols enhances human gammadelta-T cell proliferation and reduces the number of symptoms associated with colds and influenza: a randomized, placebo-controlled intervention study. Nutrition journal 12: 161.
51. Jin, Y. J., J. Friedman, and S. J. Burakoff. 1998. Regulation of tyrosine phosphorylation in isolated T cell membrane by inhibition of protein tyrosine phosphatases. J Immunol 161: 1743-1750.
52. Saunders, A. E., and P. Johnson. 2010. Modulation of immune cell signalling by the leukocyte common tyrosine phosphatase, CD45. Cell Signal 22: 339-348.
53. Pollard, T. D., and J. A. Cooper. 2009. Actin, a central player in cell shape and movement. Science 326: 1208-1212.
54. Jahnsen, F. L., E. Gran, R. Haye, and P. Brandtzaeg. 2004. Human Nasal Mucosa Contains Antigen-Presenting Cells of Strikingly Different Functional Phenotypes. American Journal of Respiratory Cell and Molecular Biology 30: 31-37.
55. Leaker, B. R., V. A. Malkov, R. Mogg, M. K. Ruddy, G. C. Nicholson, A. J. Tan, C. Tribouley, G. Chen, I. De Lepeleire, N. A. Calder, H. Chung, P. Lavender, L. N. Carayannopoulos, and T. T. Hansel. 2016. The nasal mucosal late allergic reaction to grass pollen involves type 2 inflammation (IL-5 and IL-13), the inflammasome (IL-1β), and complement. Mucosal Immunology 10: 408.
56. Lee, H., D. Ruane, K. Law, Y. Ho, A. Garg, A. Rahman, D. Esterházy, C. Cheong, E. Goljo, A. G. Sikora, D. Mucida, B. K. Chen, S. Govindraj, G. Breton, and S. Mehandru. 2015. Phenotype and function of nasal dendritic cells. Mucosal Immunology 8: 1083.